🔎 Trials Near Me

Hjem › Type 1-diabetes › Washington › Seattle

Type 1-diabetes kliniske forsøg i Seattle, WA

18 studier for Type 1-diabetes søger deltagere på steder i og omkring Seattle (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Type 1 Diabetes Extension Study

RekruttererObservationsstudie
  • Benaroya Research Institute, Seattle
Alder 8 til 35 · Alle køn · Opdateret 18. sep. 2026 · NCT02734277

METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)

RekruttererFase 2
  • University of Washington Medicine Diabetes Institute (UWMDI), Seattle
Alder 18 til 69 · Alle køn · Opdateret 15. sep. 2026 · NCT07699380

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

RekruttererFase 3
  • Benaroya Research Institute at Virginia Mason- Site Number : 8400038, Seattle
Alder 1 til 25 · Alle køn · Opdateret 14. sep. 2026 · NCT07088068

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

RekruttererFase 1/2
  • Benaroya Research Institute, Seattle
  • University of Washington Diabetes Institute, Seattle
Alder 12 til 35 · Alle køn · Opdateret 11. sep. 2026 · NCT06783309

Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

RekruttererFase 2
  • Benaroya Research Institute, Seattle
Alder 4 til 34 · Alle køn · Opdateret 9. sep. 2026 · NCT07216391

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

RekruttererFase 2
  • Benaroya Research Institute, Seattle
Alder 8 til 45 · Alle køn · Opdateret 8. sep. 2026 · NCT07142252

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

RekruttererFase 1/2
  • Seattle Children's Hospital, Seattle
Alder 9 til 20 · Alle køn · Opdateret 2. sep. 2026 · NCT07061574

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

RekruttererFase 2
  • Benaroya Research Institute at Virginia Mason, Seattle
Alder 5 til 40 · Alle køn · Opdateret 24. aug. 2026 · NCT07187531

Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery

Rekrutterer
  • University of Washington, Seattle
Alder 18 til 65 · Alle køn · Opdateret 16. jul. 2026 · NCT06880835

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

RekruttererFase 2
  • University of Washington, Seattle
Alder 18 og opefter · Alle køn · Opdateret 2. jun. 2026 · NCT05822609

Kidney Precision Medicine Project

RekruttererObservationsstudie
  • University of Washington, Seattle
Alder 18 og opefter · Alle køn · Opdateret 14. apr. 2026 · NCT04334707

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

RekruttererFase 3
  • University of Washington, Seattle
Alder 18 til 75 · Alle køn · Opdateret 24. mar. 2026 · NCT06217302

Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes

RekruttererFase 3
  • University of Washington Medicine Diabetes Institute (UWMDI), Seattle
Alder 18 til 49 · Alle køn · Opdateret 4. mar. 2026 · NCT05819138

EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)

RekruttererObservationsstudie
  • Benaroya Research Institute, Seattle
Op til 70 år · Alle køn · Opdateret 19. dec. 2025 · NCT03369821

InvesT1D: Promoting Adolescent Investment in Diabetes Care

Rekrutterer
  • Seattle Children's, Seattle
Alder 12 og opefter · Alle køn · Opdateret 16. dec. 2025 · NCT06384911

TrialNet Pathway to Prevention of T1D

RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
  • Benaroya Research Institute, Seattle
Alder 2 til 45 · Alle køn · Opdateret 1. jul. 2025 · NCT00097292

MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes

RekruttererFase 1
  • Seattle Children's Hospital, Seattle
Alder 12 til 25 · Alle køn · Opdateret 13. jun. 2025 · NCT05065372

Type 1-diabetes forsøg i andre byer

Andre studier i Seattle

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.